Thomas Galvin Alcon Inc ALC-N TOP PICK Sep 17, 2004

Proad product array. Not widely followed. Very strong grower.

Thomas Galvin

Owned

Unlock Rating

$75.600

Stock price when the opinion was issued

biotechnology pharmaceutical

It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

Get Signals Create your Watchlist

You might be interested:

BUY ON WEAKNESS

Medical devices are the one area he's been willing to be in. He likes ABT as a diversified medical device player. Another go-to name is ALC, which focuses on eye health.

Most Recent Experts

Chris Blumas

at Raymond James Investment Counsel Ltd.

Stockchase Insights

5i Research

James Telfser

Ewing Morris & Co. Investment Partners

Hap (Robert) Sneddon FCSI

Castlemoore Inc.

Stan Wong

Private Wealth Management, ScotiaMcleod

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : hello@stockchase.com.

Thomas Galvin Alcon Inc ALC-N TOP PICK Sep 17, 2004

You might be interested:

Alcon Inc(ALC-N)

Latest Buy Signals

Today's Top Picks

Popular Articles

Latest Sell Signals